Astedfarma Solutions Limited Filleted Accounts Cover
Astedfarma Solutions Limited
Company No. SC686603
Unaudited Accounts
31 January 2023
Astedfarma Solutions Limited Balance Sheet Registrar
at
31 January 2023
Company No.
SC686603
2023
2022
£
£
Fixed assets
324487
Current assets
5,75927,335
Creditors: Amounts falling due within one year
(7,889)
(18,445)
Net current assets
(2,130)
8,890
Total assets less current liabilities
(1,806)
9,377
Accruals and deferred income
(849)
(850)
(2,655)
8,527
Capital and reserves
(2,655)
8,527
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 - The Financial Reporting Standard applicable to the Micro-entities Regime.
2
Employees
2023
2022
Number
Number
The average monthly number of employees (including directors) during the year was:
2
2
3
General information
Its registered number is:
SC686603
Its registered office is:
19 HEWSON WAY
EDINBURGH
EH16 4WF
For the year ended 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 11 November 2023 and signed on its behalf by:
M.N. Edoo - Director
Astedfarma Solutions LimitedSC68660331 January 202301 February 2022false11 November 2023BTCSoftware AP Solution 2023 10.3.0110.3.01The principal activity of the company during the year under review was pharmaceutical services. SC6866032022-02-012023-01-31SC6866032023-01-31SC6866032022-01-31SC686603core:WithinOneYear2023-01-31SC686603core:WithinOneYear2022-01-31SC6866032021-01-202022-01-31SC686603bus:RegisteredOffice2022-02-012023-01-31SC6866032022-02-01SC686603bus:Micro-entities2022-02-012023-01-31SC686603bus:FullAccounts2022-02-012023-01-31SC686603bus:AuditExempt-NoAccountantsReport2022-02-012023-01-31SC686603bus:Director12022-02-012023-01-31SC686603bus:PrivateLimitedCompanyLtd2022-02-012023-01-31iso4217:GBPxbrli:pure